Thyme Care的动态

Don’t miss our upcoming webinar on Harnessing Real-World Data for Market Access Success! ? Hear from WEP's Senior Market Access Leadership Team about the transformative impact of Real World Data (RWD) in rare diseases, oncology, and advanced therapies. ? Dive deep into live examples of how RWD has supported market access outcomes and learn best practices for conducting an effective RWD study. ? Click the link below to register: ? https://lnkd.in/dpraFQFn ? We are really looking forward to sharing our expertise!? #RealWorldData #MarketAccess #WithEveryPatient

Disparities in healthcare access based on factors like race, ethnicity, and socioeconomic status contribute to unequal cancer outcomes. Join the FDA Oncology Center of Excellence for a Conversation on Cancer virtual public panel discussion on April 23: Strength in Numbers - Increasing Awareness, Decreasing Disparities. Register here to receive webinar link: https://lnkd.in/dREXNdEE

Disparities in healthcare access based on factors like race, ethnicity, and socioeconomic status contribute to unequal cancer outcomes. Join the FDA Oncology Center of Excellence for a Conversation on Cancer virtual public panel discussion on April 23: Strength in Numbers - Increasing Awareness, Decreasing Disparities. Register here to receive webinar link:?https://lnkd.in/dREXNdEE

This is one of the single, most important initiatives taking place right now. It is imperatitive that every organization doesn’t just know the details involved with this, but can execute this methodology. It starts with a comprehensive understanding of the draft guidance given in June of 2021, from this same office. How you set up the clinical trial is second to how you recruit the patients. I have found very few that grasp, or understand these two, when consulting. The future of every organization’s success will soon hinge upon that organization’s vision, strategy, and execution. The ability to simulate the study on the front end will be the most critical point of all of this. Better have the right vendors as partners. Good luck to everyone! #FEWUNDERSTAND

The rapid evolution of cancer care creates many challenges for providers. From navigating new technology deployment, to #staffing shortages, and rising care costs - Varian's Advanced Oncology Solutions is your trusted partner.? ? Our subject matter experts bring a holistic approach to optimizing and standardizing your clinical operations and workflows so you can plan for the future while addressing today’s challenges. Visit us at #ESTRO24 to learn more.?

The precision medicine industry is continuously evolving, increasing the amount of available data. Without an effective way to filter and apply this data, it loses its potential to yield powerful results for patient care. Built with the capabilities that allow you to keep up with, navigate through, and analyze this ever-expanding information, GenomOncology's flexible solution suite can strengthen your workflows and processes, resulting in more comprehensible, efficient cancer care. Learn more about our precision oncology solutions today: https://ow.ly/NgT350Qyo4z #precisiononcology #precisionmedicine

What an insightful few days for the Flatiron Health Germany team at #DGHO2024 - an incredibly important hematology and oncology conference in Germany! Our conversations with oncology clinics underscored a pressing challenge: care data is often underutilized and there is a huge need to unlock EHR data for research. In the German healthcare landscape, a variety of solutions and registries are emerging, each tailored to address specific challenges within oncology. These initiatives highlight the intricate nature of healthcare data and the critical need for collaboration. By embracing the idea that diverse Real-World Evidence (RWE) approaches can coexist and complement each other, we can harness the strengths of each system to improve patient care and enhance research outcomes. Let's improve #cancercare by learning from every patient's experience!

Patients and society won’t reap the benefits of precision oncology unless we democratize this data, that is, make it available to the patients who need it when they need it. With a few practical improvements to current care pathways, we could achieve this, meet the need for urgency, and empower patients. Stacy Hurt ??, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/gBkJMKt2 #PrecisionOncology #NovelInsights #PatientsFirst #PatientData #ASCO24

Two big challenges on my plate this week: ? 1?? Figuring out how to manage with less IV fluid than I had last week. 2?? Unraveling the mysteries of the microbiome and its impact on immunotherapy. We need answers, and we need them fast! ????? ?? Tune in to the next episode of Oncology Unscripted! Releasing soon: https://lnkd.in/eFxKqiQp

?? Day four at the 2024 ASCO Annual Meeting! It’s great to be here and engage in transformative discussions with industry leaders and oncology professionals. Excited to (re)connect and absorb insights that drive cancer care forward. Attendees are invited to book a meeting with us today and hear more on a decade's worth of breakthroughs in global patient access, courtesy of Karlijn Doorn, PhD and Daniele Tagliente. https://lnkd.in/epdyrvHn From pioneering expanded access programs (#EAPs) to harnessing real-world data (#RWD), we're here to revolutionize access and participation in clinical trials. We're open to discussions about collaborations that leave a lasting impact. #ASCO2024 #Oncology #RealWorldData #ExpandedAccess